Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2017

View Archived Issues

EMA's CHMP grants positive opinion for dupixent for the treatment of atopic dermatitis

FDA grants clearance to first neonatal magnetic resonance imaging device

DNA vaccines targeting alpha-synuclein show promise for the treatment of dementia

EMA committee backs approval of Janssen's Symtuza

FDA gives orphan drug exclusivity to CSL Behring's Haegarda

FDA approves new self-injectable formulation of Benlysta

FDA awards fast track designation to Valneva's Lyme disease vaccine candidate VLA-15

AbbVie's Humira receives positive opinion from EMA for uveitis

Phase I PK/PD data presented for Eisai's PDE9A inhibitor E-2027

Lutathera receives positive opinion from EMA for GEP-NETs

GSK and Innoviva seek E.U. approval of extended use of Relvar Ellipta

Chugai files for Japanese approval of emicizumab in hemophilia A

ORIC Pharmaceuticals presents glucocorticoid receptor antagonists

Council of Scientific and Industrial Research divulges compounds for vitiligo treatment

CHMP supports approval of Novartis' Rydapt in E.U.

Chiesi Farmaceutici discloses MAPK14 inhibitors

Xermelo obtains positive opinion from EMA committee

NeuroDerm to be acquired by Mitsubishi Tanabe Pharma

Cancer Research Technology discovers TTK inhibitors

CHMP grants positive opinion for Keytruda in urothelial carcinoma

Sichuan Haisco Pharmaceutical discovers compounds for asthma treatment

CHMP recommends approval of avelumab for metastatic Merkel cell carcinoma

CHMP issues negative opinion on Vanda Pharmaceuticals' Fanaptum

EMA committee issues new Day 180 list of outstanding issues for abaloparatide

Tissue Regenix to acquire CellRight Technologies

Identified a rare variant in ADAM17 gene tied to familial Alzheimer's disease

EMA's CHMP recommends approval of Gazyvaro for previously untreated advanced follicular lymphoma

EMA committee recommends approvals for Tecentriq in NSCLC and metastatic urothelial carcinoma

RoActemra recommended for approval in E.U. for giant cell arteritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...